CALLEXE INJECTIONNOV-2011

CALLEXE Injection is an alternative for adult patients (16 years and older) when oral administration is temporarily not feasible.

Partial Onset Seizures

CALLEXE is indicated as adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy.

Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy 

CALLEXE is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults with juvenile myoclonic epilepsy.

Primary Generalized Tonic-Clonic Seizures

CALLEXE is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults with idiopathic generalized epilepsy.

View more

BLOKIUM CORTNOV-2011

Symptomatic and short duration treatment when the patient does not respond to monotherapy for acute musculoskeletal inflammatory processes.

The injectable treatment is reserved for cases in which oral treatment is not possible or for which there has been no response.

View more

CORTICAS L UDOCT-2011

Atopic dermatitis, angioedema, urticaria, perennial and seasonal allergic rhinitis, allergic reactions, food and drug allergy, allergic contact dermatitis and allergic-type ocular manifestations, such as allergic conjunctivitis. 

View more

VALCASMAR-2011

Epilepsy: VALCAS is indicated as a monotherapy and in combination for patients with partial and complex crisis that occur in isolation or associated with other type of crisis.

VALCAS is also indicated as a monotherapy or in combination in the treatment of patients with simple and complex absence crisis, and as an adjuvant in patients with multiple crisis that include absence.

Mania: VALCAS is indicated for the treatment of maniac episodes associated with bipolar disorder.

Migraine: VALCAS is indicated for the prophylaxis of migraines. 

Valproic acid may be harmful for the fetus; therefore, the use of VALCAS should be considered in women of childbearing potential only after a thorough discussion about this risk with the patient and after assessing its use against the potential drug benefits.

View more

PELMEC PLUSMAR-2011

PELMEC PLUS is indicated for patients for whom treatment with both drugs is adequate due to the coexistence of high blood pressure and/or chronic or vasospastic angina associated with hypercholesterolemia and/or dyslipidemia. 

View more